IAASB Quarterly Board Meeting - March 15-19, 2021

March 15 - 19, 2021

Meeting Summary

Agenda

Agenda Papers

Agenda Item 1 - Introduction and Opening Remarks

20210315-IAASB-Agenda Item 1 -Introduction and Opening Remarks-Final (112K) 20210315-IAASB-Agenda Item 1-A-Draft Public Minutes of the Virtual Meeting for December 2020-(Clean) (140K) 20210315-IAASB-Agenda Item 1-B-Draft Public Minutes of the Virtual Meeting for December 2020-(Marked) (143K) 20210315-IAASB-Agenda Item 1-C-Draft Public Minutes of the Virtual Meetings Held on January 26-(Clean) (59K) 20210315-IAASB-Agenda Item 1-D-Draft Public Minutes of the Virtual Meetings Held on January 26-(Marked) (59K) 20210315-IAASB-Agenda Item 1-E-Draft Public Minutes of the Virtual Meetings Held on February 10-11-(Clean) (75K)

Agenda Item 2 - Audit Evidence

20210315-IAASB-Agenda Item 2 - Audit Evidence Issues Paper (final) (199K) 20210315-IAASB-Agenda Item 2-A - Audit Evidence Possible Application Material Related to Selected Topics Discussed in Agenda Item 2 (85K) 20210315-IAASB-Agenda Item 2-B Audit Evidence Visual Illustration (For Reference) (31K) 20210315-IAASB-Agenda Item 2-C- Audit Evidence Extant ISA 500 Renumbered (For Reference) (118K)

Agenda Item 3 - Extended External Reporting (EER)

20210315-IAASB-Agenda Item 3 -Extended External Reporting (EER)-Issues Paper (116K) 20210315-IAASB-Agenda Item 3-A-Extended External Reporting (EER) Guidance-(Marked to December 2020) (2 MB) 20210315-IAASB-Agenda Item 3-B-Extended External Reporting (EER) Guidance - Clean (2 MB) 20210315-IAASB-Agenda Item 3-B-UPDATED Extended External Reporting (EER) Guidance (2.2 MB)

Agenda Item 4 - Audits of Less Complex Entities

20210315-IAASB-Agenda Item 4-LCE Issues (Final) (156K) 20210315-IAASB-Agenda Item 4A-Draft ISA for LCE (Final) (578K) 20210315-IAASB-Agenda Item 4B-(1)-Proportionality Mapping Draft ISA for LCE (Final) (1.3 MB) 20210315-IAASB-Agenda Item 4B-(2)-Proportionality Mapping Draft ISA for LCE (Final) (1.9 MB)

Agenda Item 5 - ISA 600 Group Audits

20210315-IAASB-Agenda Item 5 -ISA 600-Issues Paper (392K) 20210315-IAASB-Agenda Item 5A-ISA 600-Proposed ISA 600 (Revised)-Marked (458K) 20210315-IAASB-Agenda Item 5B-ISA 600-Proposed ISA 600 (Revised)-Clean (392K) 20210315-IAASB-Agenda Item5-ISA 600-Supplement A.1-Q10 NVivo Report-Respondent Comments (188K) 20210315-IAASB-Agenda Item5-ISA 600-Supplement A.2-Q11 NVivo Report-Respondent Comments (220K) 20210315-IAASB-Agenda Item5-ISA 600-Supplement A.3-Q11(a) NVivo Report-Respondent Comments (175K) 20210315-IAASB-Agenda Item5-ISA 600-Supplement A.4-Q11(b) NVivo Report-Respondent Comments (144K) 20210315-IAASB-Agenda Item5-ISA 600-Supplement B.1-B.4-NVivo Summary Analysis (55K)

Audio

IAASB Board Meeting - March 15 2021 - Virtual Session 1 (19 MB)
Opening Remarks
Agenda Item 2 - Audit Evidence (Issues)
IAASB Board Meeting - March 15 2021 - Virtual Session 2 (10.6 MB)
Agenda Item 3 - EER Assurance (Approval)
IAASB Board Meeting - March 16 2021 - Virtual Session 3 (22.3 MB)
Agenda Item 4 - LCE Standard (Issues and Read)
IAASB Board Meeting - March 17 2021 - Virtual Session 4 (20.3 MB)
Agenda Item 4 - LCE Standard (Issues and Read)
IAASB Board Meeting - March 18 2021 - Virtual Session 5 (19.9 MB)
Agenda Item 3 - EER Assurance (Approval)
Agenda Item 5 - ISA 600 (Revised) (Issues)
IAASB Board Meeting - March 19 2021 - Virtual Session 6 (15.3 MB)
Agenda Item 5 - ISA 600 (Revised) (Issues)

Presentations

 
 

Thank you for your interest in our publications. These valuable works are the product of substantial time, effort and resources, which you acknowledge by accepting the following terms of use. You may not reproduce, store, transmit in any form or by any means, with the exception of non-commercial use (e.g., professional and personal reference and research work), translate, modify or create derivative works or adaptations based on such publications, or any part thereof, without the prior written permission of IFAC.

Our reproduction and translation policies, as well as our online permission request and inquiry system, are accessible on the Permissions Information web page.

For additional information, please read our website Terms of Use. ALL RIGHTS RESERVED.

Agree